Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Moleculin Biotech, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 25 | 17 | −8 |
| SharesConverted for a 1-for-25 split | 31.1K | 95.2K | +64.1K (+205.9%) |
| Value | $412.7K | $315.2K | −$97.5K (−23.6%) |
New holders (5)
Institutions that held Moleculin Biotech, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 33,085 | $109.5K | 0.00% |
| Jane Street Group, LLC | 22,550 | $74.6K | 0.00% |
| EFG International AG | 434 | $1.44K | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 281 | $930 | 0.00% |
| Danske Bank A/S | 2 | $7 | 0.00% |
Sold out (13)
Institutions that held Moleculin Biotech, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| HRT Financial LP | 115,190 | $61.0K |
| LPL Financial LLC | 58,080 | $30.8K |
| Ieq Capital, LLC | 36,363 | $19.3K |
| Wealth Dimensions Group, Ltd. | 20,000 | $10.6K |
| Cambridge Investment Research Advisors, Inc. | 12,781 | $7.00K |
| Goldman Sachs Group Inc | 12,752 | $6.76K |
| Truist Financial Corp | 10,500 | $5.57K |
| Ethos Financial Group, LLC | 10,034 | $5.32K |
| Moors & Cabot, Inc. | 10,000 | $5.30K |
| Bogart Wealth, LLC | 300 | $159 |
| North Star Investment Management Corp. | 17 | $9 |
| NBC Securities, Inc. | 14 | $7 |
| Royal Bank of Canada | 1 | $0 |